Abstract: To explore the feasibility and clinical value of a new classification for resectable intrahepatic cholangiocarcinoma (IHCC) according to the actual anatomy. The data of 135 patients with IHCC who were admitted to the Department of Hepatopancreatobiliary SurgerySecond Affiliated Hospital of Zhejiang University School of Medicine from November 2011 to November 2020 after discussion by a multidisciplinary team and planned to undergo radical resection were analyzed retrospectively. There were 77 males and 58 females,with a median age of 61 years (range:26 to 86 years),of which 38 cases had vascular invasion. This new classification was carried out independently by two hepatobiliary surgeons. First,a preliminary classification was made based on the location of the tumor,and then the final classification was based on vascular invasion. All patients were followed up by telephone,and the follow-up was as of November 2020. Survival time is defined as the time after surgery to follow-up or death. Log-rank test was used to compare patients' median recurrence-free survival and overall survival time. The Cox proportional hazard model was used to analyze the prognosis factors of the overall survival time of patients with IHCC. Among the 135 patients,129 underwent R0 resection and 6 underwent R1 resection. According to the actual anatomy,28 cases (20.7%) belonged to segmental type, 43 cases (31.9%) belonged to branch type, 64 cases (47.4%). The median survival time of all patients was 35.2 months(95%:21.3 to 70.5 months),the 1-year cumulative survival rate was 75.1%,the 3-year cumulative survival rate was 45.8%,and the 5-year cumulative survival rate was 39.0%. After grouping according to the classification,the median survival time of segmental patients was 36.9 months (more than 50% of patients reached the median survival time),and the median survival time of branched patients was 33.8 months (95%:16.8 to 38.5);The median survival time of lobe patients was 25.0 months (95%:13.6 to 58.7). The result of Log-rank test between groups indicated that the median survival time of patients with segmental type was better than that of patients with branch and lobe type(=2.03,95%:1.24 to 3.64,=0.006);There was no significant difference in survival time between patients with branch type and lobe type (=0.685). The results of the multivariate analysis of the Cox risk ratio model suggested that the actual anatomical location classification (=2.32,95%:1.10 to 4.92,=0.028) and the postoperative lymph node metastasis rate (=2.06,95%:1.24 to 3.45,=0.005) were independent factors related to survival after radical resection of IHCC patients. It is simple and convenient to classify resectable IHCC by actual anatomy,which can be used to preliminarily judge the prognosis of patients and provide a feasible classification scheme for the clinic.

New WHO Classification Changing the Strategy of Clinical Treatment--A Recognition of Inflammatory Myofibroblastic Tumor

Clinicopathological analysis of imflammatory myofibroblastic tumor in head and neck

[The clinical value of classification of hilar cholangiocarcinoma based on actual anatomy].

Inflammatory Myofibroblastic Tumor of Bladder: a Clinicopathologic Study of Five Cases

Changes of 2015 WHO Histological Classiifcation of Lung Cancer and the Clinical Signiifcance

[New WHO Classification of Lymphoid Neoplasms: Understanding and Consideration].

[Changes in WHO classification of adrenal tumors and new ideas for multi-dimensional diagnosis and treatment]

Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors

Interpretation and reunderstanding of the updated pathological classification of renal tumors of World Health Organization in 2022

Independent Validation of Distinct Clinicopathological Features and Prognosis among Usual-Type, Mucinous-Type and Gastric-Type Endocervical Adenocarcinoma Categorised by New WHO Classification (2020).

[New pathological classification and clinical implications of pituitary neuroendocrine tumors of the 2022 WHO version].

New opinions of colorectal cancer in 2010

Classificatory updates in verrucous and cuniculatum carcinomas: Insights from the 5th edition of WHO-IARC head and neck tumor classification

A Timely Update of Immunohistochemistry and Molecular Classification in the Diagnosis and Risk Assessment of Endometrial Carcinomas

Surgical interpretation of the WHO subclassification of intrahepatic cholangiocarcinoma: a narrative review

Myoepithelial and epithelial-myoepithelial, mesenchymal and fibroepithelial breast lesions: updates from the WHO Classification of Tumours of the Breast 2012

The enlightenments from ITMIG Consensus on WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting.

Clinicopathologic study based on 2 056 cases of pulmonary resection of lung adenocarcinoma

[A new classification of intrahepatic cholangiocarcinoma based on actual anatomy:a series of 135 cases].

Interpretation on Pediatric⁃type Diffuse Gliomas in the 2021 WHO Classification of Tumors of the Central Nervous System (fifth Edition)

Update of Pathological Diagnosis of Pulmonary Neuroendocrine Tumor